000 | 01580 a2200493 4500 | ||
---|---|---|---|
005 | 20250513050235.0 | ||
264 | 0 | _c19950406 | |
008 | 199504s 0 0 eng d | ||
022 | _a1043-1802 | ||
024 | 7 |
_a10.1021/bc00020a003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aApelgren, L D | |
245 | 0 | 0 |
_aChemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. _h[electronic resource] |
260 |
_bBioconjugate chemistry _c |
||
300 |
_a121-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xpathology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotoxins _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
700 | 1 | _aBailey, D L | |
700 | 1 | _aBriggs, S L | |
700 | 1 | _aBarton, R L | |
700 | 1 | _aGuttman-Carlisle, D | |
700 | 1 | _aKoppel, G A | |
700 | 1 | _aNichols, C L | |
700 | 1 | _aScott, W L | |
700 | 1 | _aLindstrom, T D | |
700 | 1 | _aBaker, A L | |
773 | 0 |
_tBioconjugate chemistry _gvol. 4 _gno. 2 _gp. 121-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/bc00020a003 _zAvailable from publisher's website |
999 |
_c7872981 _d7872981 |